130 related articles for article (PubMed ID: 3536081)
1. Cancer procoagulant in human tumor cells: evidence from melanoma patients.
Donati MB; Gambacorti-Passerini C; Casali B; Falanga A; Vannotti P; Fossati G; Semeraro N; Gordon SG
Cancer Res; 1986 Dec; 46(12 Pt 1):6471-4. PubMed ID: 3536081
[TBL] [Abstract][Full Text] [Related]
2. Different expression of procoagulant activity in human cancer cells cultured "in vitro" or in cells isolated from human tumor tissues.
Zucchella M; Pacchiarini L; Tacconi F; Saporiti A; Grignani G
Thromb Haemost; 1993 Apr; 69(4):335-8. PubMed ID: 8497845
[TBL] [Abstract][Full Text] [Related]
3. Cancer procoagulant (CP) analysis in human WM 115 malignant melanoma cells in vitro.
Kaplinska K; Rozalski M; Krajewska U; Mielicki WP
Thromb Res; 2009 Jul; 124(3):364-7. PubMed ID: 19419757
[TBL] [Abstract][Full Text] [Related]
4. Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activity.
Donati MB; Falanga A; Consonni R; Alessio MG; Bassan R; Buelli M; Borin L; Catani L; Pogliani E; Gugliotta L
Thromb Haemost; 1990 Aug; 64(1):11-6. PubMed ID: 2274915
[TBL] [Abstract][Full Text] [Related]
5. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells.
Dvorak HF; Van DeWater L; Bitzer AM; Dvorak AM; Anderson D; Harvey VS; Bach R; Davis GL; DeWolf W; Carvalho AC
Cancer Res; 1983 Sep; 43(9):4434-42. PubMed ID: 6347372
[TBL] [Abstract][Full Text] [Related]
6. Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue.
Gordon SG; Mielicki WP
Blood Coagul Fibrinolysis; 1997 Mar; 8(2):73-86. PubMed ID: 9518049
[TBL] [Abstract][Full Text] [Related]
7. Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics.
Falanga A; Bolognese Dalessandro AP; Casali B; Roncaglioni MC; Donati MB
Int J Cancer; 1987 Jun; 39(6):774-7. PubMed ID: 3294610
[TBL] [Abstract][Full Text] [Related]
8. Cancer procoagulant in acute lymphoblastic leukemia.
Alessio MG; Falanga A; Consonni R; Bassan R; Minetti B; Donati MB; Barbui T
Eur J Haematol; 1990 Aug; 45(2):78-81. PubMed ID: 2209822
[TBL] [Abstract][Full Text] [Related]
9. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
[TBL] [Abstract][Full Text] [Related]
10. [Cancer procoagulant (CP)].
Szajda SD; Darewicz B; Gorzel M; Zalewska B; Skrzydlewski Z; Kudelski J; Domel T
Przegl Lek; 2005; 62(3):169-72. PubMed ID: 16171148
[TBL] [Abstract][Full Text] [Related]
11. Comparison of procoagulant activities in extracts of normal and malignant human tissue.
Gordon SG; Franks JJ; Lewis BJ
J Natl Cancer Inst; 1979 Apr; 62(4):773-6. PubMed ID: 285292
[TBL] [Abstract][Full Text] [Related]
12. Factor X-activating activity from Guerin epithelioma.
Mielicki W; Wierzbicki R
Neoplasma; 1988; 35(3):279-84. PubMed ID: 3405336
[TBL] [Abstract][Full Text] [Related]
13. Effect of cancer procoagulant (CP) on the growth and adhesion of MCF-7 cells to vitronectin in vitro.
Kamocka M; Rózalski M; Krajewska U; Wierzbicki R; Mielicki WP
Cancer Lett; 2005 May; 222(1):89-94. PubMed ID: 15837545
[TBL] [Abstract][Full Text] [Related]
14. Direct analysis reveals an absence of gamma-carboxyglutamic acid in cancer procoagulant from human tissues.
Kaplinska K; Mielicki WP
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):315-20. PubMed ID: 19448531
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of platelet activation by cultured human cancer cells and cells freshly isolated from tumor tissues.
Grignani G; Pacchiarini L; Ricetti MM; Dionigi P; Jemos V; Zucchella M; Fratino P
Invasion Metastasis; 1989; 9(5):298-309. PubMed ID: 2767927
[TBL] [Abstract][Full Text] [Related]
16. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
17. Procoagulant activity in cancer cells is dependent on tissue factor expression.
Hu T; Bach RR; Horton R; Konigsberg WH; Todd MB
Oncol Res; 1994; 6(7):321-7. PubMed ID: 7865907
[TBL] [Abstract][Full Text] [Related]
18. A new procoagulant in acute leukemia.
Falanga A; Alessio MG; Donati MB; Barbui T
Blood; 1988 Apr; 71(4):870-5. PubMed ID: 3355894
[TBL] [Abstract][Full Text] [Related]
19. Coagulation activation by MC28 fibrosarcoma cells facilitates lung tumor formation.
Amirkhosravi M; Francis JL
Thromb Haemost; 1995 Jan; 73(1):59-65. PubMed ID: 7740497
[TBL] [Abstract][Full Text] [Related]
20. Proaggregating and procoagulant activities of human mesothelioma tumor cells at different stages of "in vitro" culture.
Pacchiarini L; Meloni F; Zucchella M; Mangiarotti P; Tacconi F; Ballabio P; Grignani G
Haematologica; 1991; 76(5):392-7. PubMed ID: 1806443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
